Company CEO Faces Federal Hearing Over The Price of EpiPens

The pharmaceutical company Mylan took a lot of heat in the public court of opinion for raising the price of EpiPens by more than 500% in recent years. On Wednesday, federal lawmakers applied pressure on Mylan’s CEO, Heather Bresch, as she testified before the House Oversight and Government Reform Committee on Capitol Hill.

Central Oregon Daily’s Anyssa Bohanan takes a look at the contentious hearing.

Join the Conversation

Related Stories